Immunotherapy for Cancer in Lucknow | Advanced Cancer Immunotherapy by Dr. N. A. Siddiqui

Cancer treatment has evolved significantly over the past decade. While surgery, chemotherapy, and radiation therapy continue to play important roles, immunotherapy has become one of the most promising advances in modern oncology. Rather than attacking cancer cells directly like chemotherapy, immunotherapy helps the body's own immune system recognize and fight cancer.

If you are looking for Immunotherapy for Cancer in Lucknow, Dr. N. A. Siddiqui, Medical Oncologist at Nabeel Cancer Care Centre, offers evidence-based cancer treatment plans that may include immunotherapy for eligible patients. Treatment recommendations are made after careful clinical evaluation and in accordance with current national and international oncology guidelines.


Meet Dr. N. A. Siddiqui

Dr. N. A. Siddiqui is a highly qualified Medical Oncologist dedicated to providing personalized cancer care with compassion and clinical excellence.

Qualifications

  • MBBS
  • MD (Medicine)
  • DNB (Medical Oncology)
  • MRCP (UK)
  • ESMO Certified Medical Oncologist
  • Certificate in Immuno-Oncology
  • PDCR

At Nabeel Cancer Care Centre, Dr. Siddiqui works with a multidisciplinary team that includes surgeons, radiation oncologists, radiologists, pathologists, oncology nurses, and supportive care specialists to provide comprehensive cancer treatment.


What is Immunotherapy?

Immunotherapy is a type of cancer treatment that enhances the body's immune system so it can identify, attack, and destroy cancer cells more effectively.

Normally, the immune system detects and removes abnormal cells. However, some cancer cells develop mechanisms to escape immune surveillance. Immunotherapy helps restore or strengthen the immune response against these cancer cells.

Unlike chemotherapy, which directly targets rapidly dividing cells, immunotherapy works by modifying immune pathways. This makes it an important treatment option for selected cancers.


How Does Immunotherapy Work?

Cancer cells can hide from the immune system by using specific proteins that suppress immune activity.

Certain immunotherapy medicines block these signals, allowing immune cells to recognize and attack cancer cells more effectively.

The response to immunotherapy varies from patient to patient, which is why careful evaluation and appropriate testing are essential before starting treatment.


Which Cancers Can Be Treated with Immunotherapy?

Immunotherapy may be considered for several types of cancer, depending on the stage of disease, biomarker testing, and current clinical guidelines.

These may include:

  • Lung Cancer
  • Melanoma
  • Kidney Cancer
  • Bladder Cancer
  • Head and Neck Cancer
  • Esophageal Cancer
  • Stomach Cancer
  • Liver Cancer
  • Cervical Cancer
  • Triple-Negative Breast Cancer (selected patients)
  • Colorectal Cancer with specific molecular characteristics
  • Hodgkin Lymphoma
  • Certain other advanced cancers

Not every patient is a candidate for immunotherapy. Treatment suitability depends on individual clinical factors.


Types of Immunotherapy

Several forms of immunotherapy are used in modern oncology.

Immune Checkpoint Inhibitors

These medicines block proteins such as PD-1, PD-L1, or CTLA-4, allowing immune cells to attack cancer more effectively.


Monoclonal Antibodies

These laboratory-produced antibodies target specific proteins on cancer cells and may also stimulate the immune system.


Cancer Vaccines

Some therapeutic vaccines help stimulate an immune response against specific cancers.


Adoptive Cell Therapy

In selected situations, immune cells may be modified or expanded before being returned to the patient's body to help fight cancer.


Who May Benefit from Immunotherapy?

Patients may be considered for immunotherapy based on factors such as:

  • Cancer type
  • Cancer stage
  • Biomarker test results (such as PD-L1)
  • Molecular profile
  • Previous treatments
  • Overall health
  • Performance status

A detailed consultation with a Medical Oncologist is necessary to determine whether immunotherapy is appropriate.


Importance of Biomarker Testing

Before recommending immunotherapy, specific laboratory tests may be required.

These may include:

  • PD-L1 Testing
  • Microsatellite Instability (MSI)
  • Mismatch Repair (MMR) Testing
  • Tumor Mutational Burden (TMB)
  • Next-Generation Sequencing (NGS), when appropriate

These tests help identify patients who are most likely to benefit from immunotherapy.


Personalized Cancer Care

Every patient is unique. At Nabeel Cancer Care Centre, Dr. N. A. Siddiqui creates individualized treatment plans after evaluating:

  • Medical history
  • Cancer stage
  • Pathology reports
  • Imaging findings
  • Biomarker results
  • Patient preferences
  • Overall health

The goal is to provide safe, evidence-based, and personalized oncology care.

How is Immunotherapy Given?

Immunotherapy is usually administered in a hospital or day-care oncology unit under the supervision of a qualified Medical Oncologist. Most immunotherapy medicines are given through an intravenous (IV) infusion, although the schedule and duration vary depending on the cancer type and treatment protocol.

Treatment may be given:

  • Every 2 weeks
  • Every 3 weeks
  • Every 4 weeks
  • According to the recommended treatment protocol

Patients are monitored during and after each infusion to ensure treatment is well tolerated.


Evaluation Before Starting Immunotherapy

Before beginning immunotherapy, Dr. N. A. Siddiqui performs a comprehensive assessment to determine whether the treatment is appropriate.

This evaluation may include:

  • Detailed medical history
  • Physical examination
  • Blood investigations
  • CT Scan, PET-CT, or MRI (when indicated)
  • Biopsy and pathology review
  • Biomarker testing (PD-L1, MSI, MMR, TMB, etc.)
  • Assessment of liver, kidney, thyroid, and lung function

This helps create a personalized treatment plan based on the patient's condition.


Benefits of Immunotherapy

For selected patients, immunotherapy may offer several advantages.

Potential benefits include:

  • Helping the immune system recognize cancer cells
  • Long-lasting response in some cancers
  • Improved disease control in eligible patients
  • Better quality of life for selected patients
  • May be combined with chemotherapy or targeted therapy
  • Personalized treatment based on biomarkers

The expected benefits depend on the cancer type, stage, and individual response.


Immunotherapy Combined with Chemotherapy

For several cancers, immunotherapy may be used along with chemotherapy to improve treatment outcomes in eligible patients.

Combination treatment may be considered for:

  • Lung Cancer
  • Triple-Negative Breast Cancer
  • Esophageal Cancer
  • Gastric (Stomach) Cancer
  • Head & Neck Cancer
  • Cervical Cancer

The treatment approach is individualized after reviewing pathology, biomarker testing, and current clinical guidelines.


Immunotherapy with Targeted Therapy

Some patients may benefit from a treatment strategy that includes targeted therapy, while others may receive immunotherapy.

The choice depends on:

  • Genetic mutations
  • Biomarker results
  • Cancer stage
  • Previous treatments
  • Overall health

Not every patient requires both treatments. Careful evaluation helps determine the most appropriate approach.


Possible Side Effects of Immunotherapy

Although immunotherapy is generally well tolerated, it can sometimes cause immune-related side effects because it stimulates the immune system.

Possible side effects include:

  • Fatigue
  • Skin rash or itching
  • Fever
  • Joint or muscle pain
  • Diarrhea
  • Cough or shortness of breath
  • Thyroid dysfunction
  • Liver inflammation
  • Colitis
  • Pneumonitis
  • Hormonal changes
  • Loss of appetite

Most side effects can be managed effectively when recognized early.


Management of Side Effects

At Nabeel Cancer Care Centre, patients are closely monitored throughout treatment.

Supportive care may include:

  • Regular blood tests
  • Thyroid function monitoring
  • Liver function assessment
  • Lung evaluation if respiratory symptoms occur
  • Medications to control inflammation when required
  • Nutritional guidance
  • Hydration support
  • Timely treatment of infections
  • Follow-up consultations after each cycle

Patients are encouraged to report any new symptoms immediately.


Nutrition During Immunotherapy

Healthy nutrition supports the immune system and helps maintain strength during cancer treatment.

General recommendations include:

  • Eat a balanced diet rich in fruits and vegetables.
  • Include adequate protein from pulses, dairy products, eggs, fish, or lean meat (as appropriate).
  • Drink sufficient fluids unless otherwise advised.
  • Choose whole grains and high-fibre foods.
  • Limit processed and sugary foods.
  • Avoid tobacco and alcohol.
  • Maintain a healthy body weight.

A dietitian may provide individualized dietary advice based on the patient's needs.


Lifestyle During Treatment

Maintaining a healthy lifestyle may improve overall well-being during immunotherapy.

Patients are encouraged to:

  • Get adequate sleep
  • Stay physically active as tolerated
  • Practice stress management
  • Avoid smoking
  • Limit alcohol consumption
  • Follow prescribed medications
  • Attend all scheduled appointments

Lifestyle modifications should always be discussed with the treating oncologist.


Follow-Up During Immunotherapy

Regular follow-up helps monitor treatment response and detect side effects early.

Follow-up may include:

  • Physical examinations
  • Blood investigations
  • CT Scan or PET-CT (when indicated)
  • Monitoring of organ function
  • Assessment of treatment response
  • Symptom review
  • Adjustment of treatment when required

The frequency of follow-up depends on the patient's diagnosis and treatment plan.


Why Choose Dr. N. A. Siddiqui?

Patients trust Dr. N. A. Siddiqui for his patient-centered approach and commitment to evidence-based cancer care.

Highlights

  • Personalized immunotherapy treatment plans
  • Expertise in Medical Oncology
  • Comprehensive cancer evaluation
  • Biomarker-guided treatment decisions
  • Multidisciplinary cancer care
  • Modern supportive care services
  • Regular monitoring throughout treatment
  • Compassionate patient counseling
  • Focus on safety, quality, and long-term follow-up

At Nabeel Cancer Care Centre, every patient receives an individualized treatment plan tailored to their diagnosis, stage of disease, biomarker profile, and overall health.


Advanced Cancer Care at Nabeel Cancer Care Centre

The centre provides comprehensive oncology services, including:

  • Medical Oncology Consultation
  • Chemotherapy
  • Immunotherapy
  • Targeted Therapy
  • Hormone Therapy
  • Precision Oncology
  • Second Opinion Consultation
  • Cancer Screening & Early Detection
  • Supportive & Palliative Care
  • Long-Term Cancer Follow-Up

Frequently Asked Questions (FAQs)

1. What is immunotherapy for cancer?

Immunotherapy is a treatment that helps the body's immune system recognize and attack cancer cells. Unlike chemotherapy, which directly targets rapidly dividing cells, immunotherapy works by strengthening or modifying the immune response.


2. Who can benefit from immunotherapy?

Immunotherapy may be recommended for selected patients with cancers such as:

  • Lung Cancer
  • Melanoma
  • Kidney Cancer
  • Bladder Cancer
  • Head & Neck Cancer
  • Esophageal Cancer
  • Liver Cancer
  • Stomach Cancer
  • Cervical Cancer
  • Hodgkin Lymphoma
  • Triple-Negative Breast Cancer (selected patients)

Treatment suitability depends on the cancer type, stage, and biomarker test results.


3. Is immunotherapy better than chemotherapy?

Neither treatment is universally better. Chemotherapy and immunotherapy work in different ways. Some patients benefit from one treatment, while others may receive a combination of both. The choice depends on the diagnosis and current clinical guidelines.


4. Is immunotherapy painful?

Immunotherapy is generally administered through an intravenous (IV) infusion. The infusion itself is usually not painful, although some patients may experience mild discomfort at the injection site.


5. How long does immunotherapy treatment last?

Treatment duration varies according to:

  • Cancer type
  • Stage of disease
  • Response to treatment
  • Overall health
  • Clinical guidelines

Some patients receive treatment for several months, while others may continue longer if clinically appropriate.


6. What are the common side effects?

Possible side effects include:

  • Fatigue
  • Skin rash
  • Itching
  • Fever
  • Diarrhea
  • Joint pain
  • Thyroid dysfunction
  • Liver inflammation
  • Cough
  • Shortness of breath

Many side effects are manageable with early recognition and appropriate medical care.


7. Is immunotherapy safe?

Immunotherapy is generally considered safe when prescribed and monitored by an experienced Medical Oncologist. Patients are regularly evaluated to identify and manage any treatment-related side effects.


8. Can immunotherapy cure cancer?

Immunotherapy has produced long-lasting responses in some patients and may improve outcomes for selected cancers. However, results vary depending on the cancer type, stage, and individual response to treatment.


9. Is biomarker testing necessary?

Yes, biomarker testing is often important before starting immunotherapy. Tests such as PD-L1, MSI, MMR, or TMB can help identify patients who are more likely to benefit from treatment.


10. Can immunotherapy be combined with chemotherapy?

Yes. For some cancers, immunotherapy is used together with chemotherapy as part of an individualized treatment plan based on current oncology guidelines.


11. Can immunotherapy be combined with targeted therapy?

In selected clinical situations, targeted therapy or immunotherapy may be recommended depending on the patient's biomarker profile and overall treatment strategy.


12. Will I lose my hair during immunotherapy?

Hair loss is uncommon with immunotherapy alone. However, if immunotherapy is combined with chemotherapy, hair loss may occur depending on the medicines used.


13. Can I continue working during treatment?

Many patients are able to continue their normal daily activities, including work, depending on how they feel during treatment. Your oncologist can provide individualized advice.


14. What foods should I eat during immunotherapy?

A balanced diet with adequate protein, fruits, vegetables, whole grains, and sufficient fluids is generally recommended. Nutritional needs may vary based on your condition and treatment.


15. How often will I need follow-up?

Regular follow-up appointments help assess treatment response, monitor side effects, and adjust treatment if necessary. The schedule is individualized for each patient.


16. Why choose Dr. N. A. Siddiqui?

Patients choose Dr. N. A. Siddiqui because of his:

  • Evidence-based Medical Oncology practice
  • Personalized cancer treatment plans
  • Expertise in immunotherapy, chemotherapy, and targeted therapy
  • Biomarker-guided treatment decisions
  • Multidisciplinary cancer care
  • Comprehensive supportive care
  • Compassionate patient counseling

17. Where can I receive immunotherapy in Lucknow?

Dr. N. A. Siddiqui provides immunotherapy consultation and personalized cancer treatment planning at Nabeel Cancer Care Centre, Lucknow, based on the patient's diagnosis and current oncology guidelines.


18. How can I book an appointment?

You can contact Nabeel Cancer Care Centre to schedule a consultation with Dr. N. A. Siddiqui for cancer evaluation, immunotherapy planning, or a second opinion.